However, the mechanism through which AKT activation promotes the survival of tumor cells remains unclear and requires further investigation; therefore, Mut p53 may diminish the killing effect of CTL on tumor cells and promote tumor immune escape (Fig. 1). This evidence concerns the gene TP53 and neoplasm.